Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516265 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors

La Merie Publishing, Feb 2011, Pages: 265


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors

The Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors as of February 2011 provides a competitor analysis in the development pipeline of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets including non-protein projects in these pharmacological classes:

- Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA)
- G-CSF & GM-CSF
- Thrombopoietin & Thrombopoiesis Stimulating Agents
- Interferon
- Insulin
- Coagulation Factors
- Human Growth Hormone (hGH)
- FSH etc
- Thrombolytics & Fibrinolytics
- Enzyme Replacement Therapies

Territories covered are the major pharmaceutical markets North America, Europe and Japan, as well as South Korea, India, China and other countries in Latin America, Africa and Australasia.

With more than US$ 50 bln in sales, therapeutic proteins represent a major category of pharmaceutical products with established therapeutic value and high economic attractiveness. As more and more of the branded products are running out of patent protection and regulatory agencies are providing better guidance, development of biosimilar versions as well as of improved next generation versions are a highly attractive goal for pharmaceutical and biotechnology as well as technology focused companies.

This report includes a compilation of current active projects in research and development of biosimilar and novel biobetter/biosuperior therapeutic proteins as well as non-protein based competitor products and an overview of approved products in regulated and less regulated markets. Competitor projects are listed in a tabular format providing Information on:

- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.


Product samples

A sample for this product is available. Please Login/Register to download this sample.

For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds